100726-38-3 Usage
Benzimidazole derivative
It is a compound derived from benzimidazole, which is a heterocyclic aromatic organic compound.
Phenyl group
The compound contains a phenyl group, which is a carbon-based ring structure with six carbon atoms and five hydrogen atoms.
Nitro substituent
One of the substituents in the compound is a nitro group (-NO2), which is a functional group consisting of an oxygen-nitrogen-oxygen chain.
Methyl substituent
Another substituent in the compound is a methyl group (-CH3), which is a carbon atom bonded to three hydrogen atoms.
Potential applications
2-(4-methyl-3-nitrophenyl)-1H-benzo[d]imidazole has potential uses in various fields, such as pharmaceuticals, agrochemicals, and material science.
Building block in organic synthesis
The compound's structure and properties make it suitable for use as a building block in the synthesis of more complex organic molecules.
Medicinal chemistry
The compound can be used in the development of new drugs and therapeutic agents due to its unique chemical structure.
Unique structural properties
The compound's specific arrangement of atoms and functional groups makes it a candidate for further study and potential applications in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 100726-38-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,0,7,2 and 6 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 100726-38:
(8*1)+(7*0)+(6*0)+(5*7)+(4*2)+(3*6)+(2*3)+(1*8)=83
83 % 10 = 3
So 100726-38-3 is a valid CAS Registry Number.
100726-38-3Relevant articles and documents
Synthesis of sulfonylated benzimidazo[2,1-a]isoquinolin-6(5H)-ones via I2O5-induced radical relay addition/cyclization of activated alkenes with sulfonylhydrazides
Tang, Yucai,Yang, Meng,Wang, Feifei,Hu, Xia,Wang, Gang
, (2021)
A facile I2O5 induced radical relay addition/cyclization of activated alkenes with sulfonylhydrazides has been successfully developed, leading to a broad range of sulfonylated benzimidazo[2,1-a]isoquinolin-6(5H)-ones in moderate to good yields. The protocol has advantages of a metal-, base-, acid-, peroxide-free process, simple operation, and broad functional group tolerance.
